Results summary | View all lists in L2L MDB | View all genes in L01A.profile.ud50 |
bleo_human_lymph_high_24hrs_up Up-regulated at 24 hours following treatment of human lymphocytes (TK6) with a high dose of bleomycin enrichment: 8.21-fold |
|||||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | Description | ||
221577_X_AT | GDF15 | C | S | growth differentiation factor 15 | |||||||||
202284_S_AT | CDKN1A | G | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | ||||||||||
208485_X_AT | CFLAR | G | P | S | CASP8 and FADD-like apoptosis regulator | ||||||||
203509_AT | SORL1 | T | E | sortilin-related receptor, L(DLR class) A repeats-containing | |||||||||
203725_AT | GADD45A | G | X | growth arrest and DNA-damage-inducible, alpha | |||||||||
206907_AT | TNFSF9 | G | X | C | S | tumor necrosis factor (ligand) superfamily, member 9 | |||||||
201471_S_AT | SQSTM1 | G | T | X | P | R | S | sequestosome 1 | |||||
201340_S_AT | ENC1 | D | ectodermal-neural cortex (with BTB-like domain) |